Packard Center researcher and Rothstein lab member chosen as a 2023 ALS Association Milton Safenowitz Postdoctoral Fellow
Congratulations to S. Can Akerman, Ph.D, a member of the Rothstein Lab, a member of the Packard Center…
Congratulations to S. Can Akerman, Ph.D, a member of the Rothstein Lab, a member of the Packard Center…
The brothers of Delta Tau Delta fraternity at Butler University in Indianapolis, Indiana recently held a 3v3 basketball…
Researchers at The Ohio State University Wexner Medical Center and College of Medicine led the creation of evidence-based…
Reposted from the NYTimes.comBy Christopher MaagPublished Sept. 6, 2023 Dan Doctoroff once had more power to decide what got built…
The Food and Drug Administration granted accelerated approval of the drug tofersen for the treatment of SOD1-ALS. Developed by…
A new set of Answer ALS project data is now available through the Answer ALS Data Portal. A…
Neuroscientists at Thomas Jefferson University have identified a new way that repeat expansion in the C9orf72 gene—the most…
Results of a new Phase 2 randomized clinical trial in 137 patients with ALS showed that treatment with…
In a new study, a team of Packard scientists identified a key intersection between two major pathways of…
For people with inherited forms of ALS, learning of their genetic predisposition can feel like a “death sentence.”…